|
Market Cap | 573.07M | EPS (ttm) | 0.37 |
P/E | 38.72 | EPS this Y | -8.88% |
Forward P/E | 11.46 | EPS next Y | 11.97% |
PEG | 16.14 | EPS past 5Y | -12.91% |
P/S | 0.58 | EPS next 5Y | 2.40% |
P/B | 2.12 | EPS Q/Q | -82.36% |
Dividend | 3.39% | Sales Q/Q | 2.17% |
Insider Own | 50.06% | Inst Own | 51.03% |
Insider Trans | 0.00% | Inst Trans | -1.80% |
Short Float | 3.10% | Earnings | May 08/a |
Analyst Recom | 4.25 | Target Price | 10.75 |
Avg Volume | 143.28K | 52W Range | 9.40 - 15.96 |
|
|
|
Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment produces specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ. |
|
|
|
Market Cap | 673.55M | EPS (ttm) | -1.47 |
P/E | - | EPS this Y | 20.43% |
Forward P/E | - | EPS next Y | 31.26% |
PEG | - | EPS past 5Y | -416.28% |
P/S | 9.65 | EPS next 5Y | 43.50% |
P/B | - | EPS Q/Q | 8.97% |
Dividend | - | Sales Q/Q | 98.76% |
Insider Own | 34.46% | Inst Own | 29.31% |
Insider Trans | 0.00% | Inst Trans | 1.71% |
Short Float | 30.83% | Earnings | May 07/a |
Analyst Recom | 2.27 | Target Price | 5.09 |
Avg Volume | 7.74M | 52W Range | 1.21 - 8.32 |
|
|
|
Luminar Technologies, Inc. is an autonomous vehicle sensor and Lidar technology company, which engages in the design, building, and marketing of long-range lidar products that address the requirements of global automotive OEMs and technology companies for autonomous driving. It operates through the Autonomy Solutions and Advanced Technologies and Services segments. The Autonomy Solutions segment includes the designing, manufacturing, and marketing of lidar sensors catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi and adjacent industries. The Advanced Technologies and Services segment provides semiconductors and related components, as well as design, test, and consulting services to the Autonomy Solutions segment and to various third-party customers, including government agencies and defense contractors, in markets generally unrelated to autonomous vehicles. The company was founded by Austin Russell and Jason Eichenholz in 2012 and is headquartered in Orlando, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Prescott Alan | Chief Legal Officer | Sep 06 '23 | Sale | 5.57 | 42,171 | 234,682 | 1,467,282 | Sep 08 04:41 PM | Fennimore Thomas | Chief Financial Officer | Sep 06 '23 | Sale | 5.57 | 18,305 | 101,867 | 692,699 | Sep 08 04:40 PM | Prescott Alan | Chief Legal Officer | Jun 05 '23 | Sale | 7.21 | 37,433 | 269,866 | 1,509,453 | Jun 07 06:02 PM | Fennimore Thomas | Chief Financial Officer | Jun 05 '23 | Sale | 7.21 | 16,543 | 119,263 | 711,004 | Jun 07 06:03 PM | Russell Austin | Chairperson, President & CEO | May 16 '23 | Buy | 6.12 | 791,113 | 4,841,849 | 4,596,798 | May 18 02:09 PM |
|
|
|
|
Market Cap | 3.78M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 12.32% |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | -1297.75% |
Dividend | - | Sales Q/Q | 183.11% |
Insider Own | 20.07% | Inst Own | 2.67% |
Insider Trans | 0.00% | Inst Trans | -27.49% |
Short Float | 1.08% | Earnings | Apr 01/b |
Analyst Recom | - | Target Price | - |
Avg Volume | 21.15K | 52W Range | 0.94 - 3.64 |
|
|
|
Sharplink Gaming, Inc. provides an online platform facilitating sports betting. It is an online technology company that connects sports fans, leagues, and sports websites to relevant and timely sports betting content. It operates through the Affiliate Marketing Services-United States and Affiliate Marketing Services-International segments. The Affiliate Marketing Services-United States segment operates a performance marketing platform which owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to the company's sportsbook and casino partners which are licensed to operate in each respective state. The Affiliate Marketing Services-International segment is a global affiliate marketing network, focused on delivering quality traffic and player acquisitions, retention and conversions to global casino gaming partners worldwide in exchange for a commission paid to the company by the partners for the new players referred to them. The company was founded by Robert Phythian in 2019 and is headquartered in Minneapolis, MN. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Phythian Rob | Chief Executive Officer | Mar 31 '24 | Option Exercise | 0.00 | 25,000 | 0 | 100,000 | Apr 03 10:28 AM | GUTKOWSKI ROBERT M | Director | Mar 31 '24 | Option Exercise | 0.00 | 10,000 | 0 | 40,000 | Apr 03 10:26 AM | MCKENZIE OBIE | Director | Mar 31 '24 | Option Exercise | 0.00 | 10,000 | 0 | 40,000 | Apr 03 10:27 AM | DeLucia Robert Michael | Chief Financial Officer | Mar 31 '24 | Option Exercise | 0.00 | 20,000 | 0 | 80,000 | Apr 03 10:26 AM | Bernhard Leslie | Director | Mar 31 '24 | Option Exercise | 0.00 | 10,000 | 0 | 40,000 | Apr 03 10:25 AM |
|
|
| |
|
Market Cap | 586.30M | EPS (ttm) | -2.14 |
P/E | - | EPS this Y | 18.56% |
Forward P/E | - | EPS next Y | 10.15% |
PEG | - | EPS past 5Y | -193.88% |
P/S | - | EPS next 5Y | - |
P/B | 3.58 | EPS Q/Q | -61.42% |
Dividend | - | Sales Q/Q | - |
Insider Own | 58.50% | Inst Own | 27.56% |
Insider Trans | 15.85% | Inst Trans | - |
Short Float | 20.52% | Earnings | Mar 01/b |
Analyst Recom | 1.50 | Target Price | 15.50 |
Avg Volume | 729.13K | 52W Range | 4.11 - 17.20 |
|
|
|
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
NELSEN ROBERT | Director | Feb 15 '24 | Buy | 6.25 | 3,200,000 | 20,000,000 | 3,200,000 | Feb 20 05:41 PM | ARCH Venture Partners X, LLC | 10% Owner | Feb 15 '24 | Buy | 6.25 | 3,200,000 | 20,000,000 | 3,200,000 | Feb 20 05:37 PM | ARCH Venture Partners XII, LLC | 10% Owner | Feb 15 '24 | Buy | 6.25 | 3,200,000 | 20,000,000 | 3,200,000 | Feb 20 05:38 PM | GV 2019 GP, L.L.C. | 10% Owner | Jun 21 '23 | Sale | 14.97 | 19,003 | 284,496 | 0 | Jun 22 05:03 PM | GV 2019 GP, L.L.C. | 10% Owner | Jun 20 '23 | Sale | 15.06 | 37,405 | 563,248 | 0 | Jun 22 05:03 PM |
|
|
|
|
Market Cap | 116.84M | EPS (ttm) | -0.50 |
P/E | - | EPS this Y | -40.52% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 2.67% |
P/S | 248.60 | EPS next 5Y | 20.00% |
P/B | 23.69 | EPS Q/Q | 23.53% |
Dividend | - | Sales Q/Q | -46.11% |
Insider Own | 1.41% | Inst Own | 2.33% |
Insider Trans | 0.00% | Inst Trans | -13.57% |
Short Float | 0.70% | Earnings | Mar 15/a |
Analyst Recom | 1.00 | Target Price | 3.00 |
Avg Volume | 420.16K | 52W Range | 0.72 - 5.88 |
|
|
|
POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada. |
|
| |
|
Market Cap | 22.33M | EPS (ttm) | -0.65 |
P/E | - | EPS this Y | 55.38% |
Forward P/E | - | EPS next Y | 44.83% |
PEG | - | EPS past 5Y | 30.33% |
P/S | 0.43 | EPS next 5Y | - |
P/B | 1.46 | EPS Q/Q | 119.80% |
Dividend | - | Sales Q/Q | -3.03% |
Insider Own | 25.99% | Inst Own | 6.96% |
Insider Trans | 0.00% | Inst Trans | -1.30% |
Short Float | 0.11% | Earnings | Apr 01/a |
Analyst Recom | 1.00 | Target Price | 7.50 |
Avg Volume | 18.01K | 52W Range | 2.60 - 6.50 |
|
|
|
Air Industries Group is an integrated tier 1 manufacturer of precision assemblies and components for mission-critical aerospace and defense applications and is a prime contractor to the U.S. Department of Defense. The company is regarded for its expertise in manufacturing parts and assemblies that are vital for flight safety and performance, including landing gear, arresting gear, engine mounts, flight controls, and jet engine components. Its products are currently deployed on profile military aircraft such as the Sikorsky Black Hawk, Lockheed Martin F-35 Lightning II (Joint Strike Fighter), F-16 Fighting Falcon, Northrop Grumman E-2C/D, Boeing F-15 Eagle, and F-18 Hornet, as well as several commercial aircraft manufactured by Airbus and Boeing. The company was founded in 1979 and is headquartered in Bay Shore, NY. |
|
|
|
Market Cap | 2.76B | EPS (ttm) | 1.61 |
P/E | 10.58 | EPS this Y | -8.95% |
Forward P/E | 10.91 | EPS next Y | 4.68% |
PEG | 1.32 | EPS past 5Y | 6.84% |
P/S | 1.77 | EPS next 5Y | 8.00% |
P/B | 1.00 | EPS Q/Q | -7.79% |
Dividend | 4.16% | Sales Q/Q | 16.34% |
Insider Own | 1.16% | Inst Own | 72.97% |
Insider Trans | -0.00% | Inst Trans | 0.12% |
Short Float | 4.57% | Earnings | Apr 16/a |
Analyst Recom | 3.00 | Target Price | 16.21 |
Avg Volume | 1.13M | 52W Range | 9.64 - 17.06 |
|
|
Today | Upgrade |
Janney |
Neutral → Buy |
$19.50 |
|
Today 09:25AM
|
Republic First Bank Seized, Sold To Fulton Financial
(Investor's Business Daily) +9.15% |
08:56AM
|
Fulton Financial Announces Pricing of $250 Million Offering of Common Stock
(Business Wire) |
08:38AM
|
These Stocks Are Moving the Most Today: Tesla, Alphabet, SoFi, Apple, Paramount, Dominos, Fulton Financial, and More
(Barrons.com) |
07:13AM
|
Fulton Financial shares rises after it buys failed Republic First Bank, announces stock offering
(Reuters) |
07:10AM
|
TIMELINE-Republic First becomes first casualty of U.S. bank crisis in 2024
(Reuters) |
06:27AM
|
Fulton Financial Announces Launch of Common Stock Offering
(Business Wire) |
06:21AM
|
Fulton Financial jumps after buying failed Republic First Bank's deposits, assets
(Reuters) |
05:34AM
|
Fulton Financial Subsidiary Acquires Substantially All Assets of Republic First Bank From FDIC; Shares Jump Premarket
(MT Newswires) |
Apr-26-24 07:03PM
|
Fulton Financial Corporation Acquires Substantially All of the Assets and Assumes Substantially All of the Deposits of Republic First Bank From the FDIC
(Business Wire) |
07:02PM
|
Regulators Seize Troubled Philadelphia Bank, Republic First
(The Wall Street Journal) |
|
Fulton Financial Corp. is financial holding company, which through its subsidiaries, engages in the provision of consumer and commercial banking products and services. It offers checking account and savings deposit products, certificates of deposit and individual retirement accounts. The company also offers investment management, trust, brokerage, insurance and investment advisory services to consumer and commercial banking customers in the market areas serviced by the subsidiary banks. The company was founded on February 8, 1982 and is headquartered in Lancaster, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Wenger E Philip | Director | Nov 07 '23 | Sale | 13.75 | 0 | 4 | 0 | Nov 08 11:52 AM | MOXLEY JAMES R III | Director | Jun 01 '23 | Option Exercise | 0.00 | 4,661 | 0 | 83,331 | Jun 05 04:31 PM | Myers Curtis J | Chairman & CEO | May 12 '23 | Buy | 9.81 | 15,000 | 147,156 | 157,044 | May 15 09:05 AM | MCCOLLOM MARK R | Sr. EVP & CFO | May 11 '23 | Buy | 9.74 | 10,000 | 97,400 | 71,503 | May 15 09:04 AM | Campbell David M | Sr Executive Vice President | May 03 '23 | Sale | 11.19 | 10,514 | 117,636 | 22,202 | May 03 04:30 PM |
|
|
| |
|
Market Cap | 264.41M | EPS (ttm) | -1.46 |
P/E | - | EPS this Y | 38.97% |
Forward P/E | - | EPS next Y | 19.49% |
PEG | - | EPS past 5Y | - |
P/S | 2.93 | EPS next 5Y | -7.30% |
P/B | 2.10 | EPS Q/Q | 30.53% |
Dividend | - | Sales Q/Q | 8.45% |
Insider Own | 3.09% | Inst Own | 64.78% |
Insider Trans | -1.28% | Inst Trans | -4.28% |
Short Float | 1.75% | Earnings | Mar 04/a |
Analyst Recom | 3.00 | Target Price | 3.00 |
Avg Volume | 2.52M | 52W Range | 0.41 - 1.75 |
|
|
|
Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and autoimmune diseases. The company was founded in 1990 and is headquartered in San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
ROBIN HOWARD W | President & CEO | Feb 20 '24 | Sale | 0.68 | 20,033 | 13,622 | 879,889 | Feb 22 08:16 PM | Zalevsky Jonathan | Chief R&D Officer | Feb 20 '24 | Sale | 0.68 | 9,014 | 6,130 | 265,025 | Feb 22 08:19 PM | Wilson Mark Andrew | Chief Legal Officer | Feb 20 '24 | Sale | 0.68 | 7,606 | 5,172 | 236,674 | Feb 22 08:17 PM | ROBIN HOWARD W | President & CEO | Nov 17 '23 | Sale | 0.49 | 19,877 | 9,740 | 899,922 | Nov 20 08:58 PM | Zalevsky Jonathan | Chief R&D Officer | Nov 17 '23 | Sale | 0.49 | 9,646 | 4,727 | 274,039 | Nov 20 09:02 PM |
|
|
|
|
Market Cap | 73.65M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 46.62% | Inst Own | 0.11% |
Insider Trans | 0.00% | Inst Trans | 1.13% |
Short Float | 1.18% | Earnings | Feb 20/b |
Analyst Recom | - | Target Price | - |
Avg Volume | 1.06M | 52W Range | 0.72 - 13.90 |
|
|
|
DIH Holding US, Inc. provides global robotics and virtual reality technology services. It serves the healthcare industry. The company was founded by Jason Chen in 2007 and is headquartered in Norwell, MA. |
|
|
|
Market Cap | 40.16M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -78.21% |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 51.56% | Inst Own | 0.00% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.49% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 874.14K | 52W Range | 0.50 - 3.54 |
|
|
|
Lichen China Ltd. engages in providing financial and taxation solutions. It also offers educational support, and software and maintenance services. The company was founded by Li Ya on April 13, 2016 and is headquartered in Jinjiang, China. |
|
|